Medical Properties Trust experienced a challenging first quarter in 2025, with total revenues decreasing to $223,799 thousand from $271,316 thousand in Q1 2024. The company reported a net loss attributable to common stockholders of $118,275 thousand, or $0.20 per diluted share, a significant improvement from the $875,625 thousand loss, or $1.46 per diluted share, in the prior year.
Total revenues for Q1 2025 were $223,799 thousand, down from $271,316 thousand in Q1 2024.
Net loss attributable to MPT common stockholders improved significantly to $118,275 thousand ($0.20 per diluted share) from $875,625 thousand ($1.46 per diluted share) in the prior year.
Funds from operations (FFO) for Q1 2025 were $16,123 thousand, a substantial increase from a negative FFO of $779,959 thousand in Q1 2024.
Normalized funds from operations (Normalized FFO) for Q1 2025 were $81,102 thousand, compared to $141,785 thousand in Q1 2024.
The forward-looking statements indicate potential for acquisitions and recapitalizations, re-tenanting of facilities, and outcomes from Prospect's Chapter 11 restructuring. However, there are significant risks related to the bankruptcy outcome, property sales, debt financing, and tenant performance.